MRK stock news
US Markets

Merck (NYSE: MRK) Stock Dips as FDA Rejects Lung Cancer Drug Co-Developed with Daiichi Sankyo

/

Merck (NYSE: MRK) stock fell during intraday trading Friday after the FDA declined to approve a lung cancer drug developed […]

Merck (NYSE: MRK) Stock Dips as FDA Rejects Lung Cancer Drug Co-Developed with Daiichi Sankyo Read More »